Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Perez de la Cruz, Jose
Format: Recurso digital
Sprache:
Veröffentlicht: Zenodo 2025
Schlagworte:
Online-Zugang:https://doi.org/10.5281/zenodo.15537526
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866901725451911168
author Perez de la Cruz, Jose
author_facet Perez de la Cruz, Jose
contents <p>This white paper presents a mathematical model projecting the progressive reduction of the latent HIV reservoir under a cyclic, low-toxicity latency reversal protocol using oral Resveratrol and N-acetylcysteine (NAC), administered alongside ART. The study simulates multiple treatment cycles and estimates functional cure probability based on reservoir decay thresholds.</p> <p>The modeling framework explores reservoir dynamics across varying per-cycle reduction rates and quantifies the relationship between residual reservoir size and the theoretical probability of post-treatment viral control. This report includes full methodological assumptions, simulation outputs, visualizations, and complete source code (Appendix A) for independent reproduction or adaptation.</p> <p>This manuscript builds upon an earlier white paper published by the author on Zenodo (DOI: <a href="https://doi.org/10.5281/zenodo.15390536">10.5281/zenodo.15390536</a>) and is intended to support early-stage HIV cure research, protocol design, and physiological modeling development. The author encourages open scientific discussion and future in vitro or in vivo validation.</p> <p>The document includes:</p> <ul> <li>Mathematical modeling assumptions</li> <li>Cycle-based simulation outputs</li> <li>Functional cure probability estimates</li> <li>Python code (Appendix A)</li> <li>Visual figures (in-line)</li> <li>A full reference list</li> </ul> <p>This version has not undergone peer review and is shared openly under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_15537526
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle Projected Reservoir Reduction and Functional Cure Probability Under a Cyclic Resveratrol + NAC Protocol for HIV Latency Reversal
Perez de la Cruz, Jose
HIV latency
HIV
Functional cure
Latency reversal agents
Resveratrol
N-acetylcysteine
NAC
Reservoir modeling
HIV cure strategies
<p>This white paper presents a mathematical model projecting the progressive reduction of the latent HIV reservoir under a cyclic, low-toxicity latency reversal protocol using oral Resveratrol and N-acetylcysteine (NAC), administered alongside ART. The study simulates multiple treatment cycles and estimates functional cure probability based on reservoir decay thresholds.</p> <p>The modeling framework explores reservoir dynamics across varying per-cycle reduction rates and quantifies the relationship between residual reservoir size and the theoretical probability of post-treatment viral control. This report includes full methodological assumptions, simulation outputs, visualizations, and complete source code (Appendix A) for independent reproduction or adaptation.</p> <p>This manuscript builds upon an earlier white paper published by the author on Zenodo (DOI: <a href="https://doi.org/10.5281/zenodo.15390536">10.5281/zenodo.15390536</a>) and is intended to support early-stage HIV cure research, protocol design, and physiological modeling development. The author encourages open scientific discussion and future in vitro or in vivo validation.</p> <p>The document includes:</p> <ul> <li>Mathematical modeling assumptions</li> <li>Cycle-based simulation outputs</li> <li>Functional cure probability estimates</li> <li>Python code (Appendix A)</li> <li>Visual figures (in-line)</li> <li>A full reference list</li> </ul> <p>This version has not undergone peer review and is shared openly under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.</p>
title Projected Reservoir Reduction and Functional Cure Probability Under a Cyclic Resveratrol + NAC Protocol for HIV Latency Reversal
topic HIV latency
HIV
Functional cure
Latency reversal agents
Resveratrol
N-acetylcysteine
NAC
Reservoir modeling
HIV cure strategies
url https://doi.org/10.5281/zenodo.15537526